Answers are grounded in this paper and cite their sources.
Shows intermediate phase formation in LaNiO3 under different gas atmospheres, indicating key insights for catalyst performance.
By in situ electron microscopy we show the intermediate phase formation during decomposition of LaNiO 3 , a model methane dry reforming (DRM) catalyst, under different gas atmospheres. By combining dark- and bright-field imaging with secondary-electron contrast and operando electronic structure characterization, we localize the coupled formation of Ni(O) particles and La 2 NiO 4 as key intermediates under DRM operation preceding full decomposition into metallic Ni and La 2 O 3 . Reduced and bar-level reactant partial pressures enable detailed observation of early decomposition stages. Ni particles formed in vacuum or DRM mixtures undergo transient surface oxidation by lattice oxygen, while highly dynamic Ni particles result from hydrogen reduction. At high temperatures, concurrent Ni formation, LaNiO 3 -to-La 2 NiO 4 transitions, Ostwald ripening, and particle fragmentation/agglomeration govern the dynamics. DRM exposure of reduction-formed Ni leads to rapid oxidation to sintering-resistant NiO with size-dependent dissolution/agglomeration characteristics. As CO 2 cannot directly oxidize Ni here, oxygen migration from the perovskite bulk drives this transient, DRM-detrimental NiO formation.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: